- https://www.vrtx.com/sites/default/files/Vertex-2018-csr.pdf
- https://jobs.brassring.com/1033/ASP/TG/cim_home.asp?partnerid=25119&siteid=5134
- http://investors.vrtx.com/
- http://investors.vrtx.com/releases.cfm
- https://investors.vrtx.com/news-releases/news-release-details/vertex-expands-new-disease-areas-and-enhances-gene-editing
- https://investors.vrtx.com/news-releases/news-release-details/vertex-selects-triple-combination-regimen-vx-445-tezacaftor-and
- https://investors.vrtx.com/news-releases/news-release-details/vertex-present-data-ecfs-conference-potential-impact-early
- https://sjobs.brassring.com/TGnewUI/Search/Home/Home?partnerid=25119&siteid=5134#home
- https://www.facebook.com/VertexPharmaInc
- https://twitter.com/VertexPharma
- https://www.linkedin.com/company/vertex-pharmaceuticals
- https://www.youtube.com/channel/UCrNu_QIE9exwVQnWKgr1toQ/featured
- https://www.vrtxspendtransparency.com/
No comments:
Post a Comment